PMID: 42214023

Semaglutide in metabolic dysfunction-associated alcohol-related liver disease: a potential dual-target therapy for metabolic dysfunction and alcohol use.

Nery Filipe

European journal of gastroenterology & hepatology · 2026

Vol. 38, Issue 7, pp. 885-886

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.